The interpretation of the results can also explain some discrepancies seen in the literature.28 Despite these controversies, results similar to those seen in our study have been published, in which poor correlation is established between HER2/neu expression and the pathological outcome in prostate cancer.29,30. The gene discussed is ERBB2; the disease is prostate carcinoma.